FindTrial
Sign In

EFFECT OF VADAVANALA CHURNA IN HYPOTHYROIDISM

AN OPEN LABEL, SINGLE ARM CLINICAL STUDY ON THE EFFECTIVENESS OF VADAVANALA CHURNA IN HYPOTHYROIDISM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032116
Enrollment
30
Registered
2021-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

Intervention1: vadavanala churna : 2 tablets of 500mg each administered thrice daily before food Control Intervention1: Not Applicable: Not Applicable

Sponsors

sri dharmasthala manjunatheshwara college of ayurveda and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.THOSE WHO ARE NEWLY DETECTED OR ON ORAL THYROXINE THERAPHY 2. SUBJECTS OF EITHER GENDER 3. SUBJECTS AGED BETWEEN 18 - 60 YEARS

Exclusion criteria

Exclusion criteria: 1.SUBJECTS WITH HISTORY OF THYROIDECTOMY, CONGENITAL HYPOTHYROIDISM, DRUG INDUCED, HYPOTHYROIDISM DUE TO INFILTRATIVE DISORDERS SACOIDOSIS, SYSTEMIC SCLEROSIS, HEMOCHROMATOSIS, PROGRESSIVE CASE OF MYXOEDEMA 2.KNOWN CASE OF RENAL, CARDIAC AND HEPATIC IMPAIRMENT 3.KNOWN CASE OF DIABETES MELLITUS AND MALIGNANT HYPERTENSION 4.PREGNANT AND LACTATING WOMEN

Design outcomes

Primary

MeasureTime frame
SERUM TSH, SERUM T3, SERUM T4Timepoint: 45 days—

Secondary

MeasureTime frame
CLINICAL SIGNS AND SYMPTOMS OF HYPOTHYROIDISM (BEFORE TREATMENT, 15TH DAY, 30TH DAY, 45TH DAY) USING BILLEWICZ DIAGNOSTIC INDEXTimepoint: 45 days—

Countries

India

Contacts

Public ContactDR GIRISH K J

sri dharmasthala manjunatheshwara college of ayurveda and hospital

girideepa@yahoo.co.in9448646866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026